StocksFin Logo
Merck & Co., Inc.
Merck & Co., Inc. country of incorporation
|
https://www.merck.com
|
Mr. Kenneth Frazier
|
67,000 employees
NYSE | Healthcare | Drug Manufacturers—General
Medtronic plc
Medtronic plc country of incorporation
|
https://www.medtronic.com
|
Mr. Omar Ishrak
|
95,000 employees
NYSE | Healthcare | Medical Devices
Q322 reported Nov 3, 2022 Reporting Period
$14.96B 13.7% vs. Q321 Revenues Q322
73.7% -0.1% vs. Q321 Gross Profit Margin
21.71% -37.5% vs. Q321 Net Profit Margin
4.48B -6.7% vs. Q321 Free Cash Flow Q322
$1.28 -29.3% vs. Q321 EPS Q322
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
0.8%
Q223
0.78%
Q223 reported Dec 1, 2022 Reporting Period
$7.59B -3.3% vs. Q222 Revenues Q223
66.58% -2.3% vs. Q222 Gross Profit Margin
5.63% -66.3% vs. Q222 Net Profit Margin
599M -66.1% vs. Q222 Free Cash Flow Q223
$0.32 -67% vs. Q222 EPS Q223
-
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
0.8%
Q223
0.78%
Ratios
As of
Sep 30, 2022
Oct 28, 2022
Quick Ratio
0.9
1.18
Current Ratio
1.46
1.76
Cash Ratio
0.48
0.33
Price to Book
4.91
2.22
Price to Sales
14.58
15.22
Price to Earnings
16.79
67.58